Institute for International Research

This page will be used to provide paid delegates of the conference with access to any presentations that were not included in the conference documentation. Only paid conference delegates have permission to access IIR online documentation.

While these presentations were not available to be included in your conference documentation, IIR is pleased to make them available to all conference delegates through this web site.

You will need the freely available Adobe Acrobat Reader, which is available by clicking here. To access the presentations:

• Click the title of the session
  
• You can choose to view the file online or save the file to your computer
  
• You can print the files and add them to your other conference materials

Using the Internet to Help Run a Clinical Study and Recruit Patients
Tuesday, April 10, 2007 / Pre-Conference
Linda Wolf, Strategic Operations, BBK WORLDWIDE; Bill Kennedy, President, PK DATA

Clinical Trial Design: Don't Shoot Yourself in the Foot
Tuesday, April 10, 2007 / Pre-Conference
Dalvir Gill, PhD, Executive Vice President, Clinical Research, PHARMANET

An Introduction to the Patient Advocate Foundation
Tuesday, April 10, 2007 / Pre-Conference
Nancy Davenport-Ennis, CEO, PATIENT ADVOCATE FOUNDATION AND NATIONAL PATIENT ADVOCATE FOUNDATION

Main Conference

Part I-Targeted Agents and Chemotherapy
Wednesday, April 11, 2007 / 9:45 AM
Grant Williams, MD, Clinical Development, Oncology MDC, GLAXOSMITHKLINE

Part II- Translated Oncology
Wednesday, April 11, 2007 / 9:45 AM
Maria Koehler MD, Clinical Development, Oncology MDC, GLAXOSMITHKLINE

Part III- Accelerated Drug Approval
Wednesday, April 11, 2007 / 10:45 AM
Grant Williams, MD, Clinical Development, Oncology MDC, GLAXOSMITHKLINE

Adaptive Designs for Clinical Trials
Wednesday, April 11, 2007 / 11:30 AM
Philip Banks, MS, Senior Director of Biostatistics and IT, PROLOGUE RESEARCH

Cardiac Concerns in Oncology Clinical Trials
Wednesday, April 11, 2007 / 2:00 PM
Christopher H. Cabell, MD, MHS, FACC, Director, Cardiac Safety, DUKE CLINICAL RESEACH INSTITUTE; Chief Executive Officer, CORESEARCH

Circulating Oncoproteins as Cancer Biomarkers for Targeted Therapies
Wednesday, April 11, 2007 / 4:15 PM
Walter P. Carney, MD, Head of Oncogene Science, BAYER HEALTHCARE

"Nuts and Bolts" of QT Assessment in Oncology Programs
Wednesday, April 11, 2007 / 4:45 PM
William Wheeler, MD, FAAC, Chief Medical Officer, Clinical Trial Services Division, SPACELABS HEALTHCARE

Two Shots on Goal - Identifying Sensitive Subpopulations
Thursday, April 12, 2007 / 10:50 AM
Peter F. Lenehan, MD, PhD, Chief Medical Officer, GENETICS SQUARED, INC.

The Evolving World of Endpoints- Where Are We?
Thursday, April 12, 2007 / 11:20 AM
Renee B. Iacona, PhD, MPH, Global Product Statistician, ASTRAZENECA PHARMACEUTICALS

Pfizer Sutent Case Study
Thursday, April 12, 2007 / 1:30 PM
Darrel P. Cohen, M.D., Ph.D., Senior Director, Oncology Clinical Development, PFIZER GLOBAL RESEARCH AND DEVELOPMENT

Imaging in Oncology Clinical Trials: Incorporating Central Review to Maximize Value
Thursday, April 12, 2007 / 2:15 PM
Rick Taranto, MBA, President, WORLDCARE CLINICAL, LLC